Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

11:15 AM - 11:25 AM ET

193 - Closing the Screening Gap: A Survivor-Led Model for Early Oral Cancer Detection in Rural India
Speaker: Sai Shreya, Vangipuram, MBBS - Sri Rama Chandra Medical College, Chennai
11:15 AM - 11:25 AM ET

200 - Radiological prior Knowledge-Guided Deep Learning for Predicting Invasiveness of Medium-Sized Pulmonary Nodules
Speaker: Huang, Canbo - Institute of Radiation Medicine, Fudan University, Shanghai, Shanghai
11:15 AM - 11:25 AM ET

206 - Safety of Maintenance Pembrolizumab (Pembro) and Concurrent Radiotherapy (RT) in Pediatric Participants with Classic Hodgkin Lymphoma (cHL) and Slow Early Response (SER) to Front-Line Chemotherapy (Chemo): Post Hoc Analysis of the KEYNOTE-667 Study
Speaker: Hoppe, Bradford, MD, FASTRO, MPH - Mayo Clinic Florida, Jacksonville, FL
11:25 AM - 11:35 AM ET

169 - A Novel Regimen of Liposomal Irinotecan Plus Capecitabine as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LipCap): A Phase II Trial
Speaker: Xiao, Linlin, MS, RT - the fourth hospital of hebei medical university, Shijiazhuang, Hebei province
11:25 AM - 11:35 AM ET

176 - Efficacy and Safety of an Adaptive Treatment Strategy for Locoregionally Advanced Nasopharyngeal Carcinoma Based on Response Stratification to Nimotuzumab Plus Induction Chemotherapy: A Prospective Multicenter Phase II Clinical Study
Speaker: Zeng, Lei, MD - The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi
11:25 AM - 11:35 AM ET

181 - Risk-Adapted Radiotherapy for Locally Advanced NSCLC: Pooled Analysis of Two Prospective Trials
Speaker: Saad, Shumaila, MD - Montefiore Medical Center, Bronx, NY
11:25 AM - 11:35 AM ET

187 - Ultra-Early Pain Relief after Stereotactic Radiosurgery for Classical Trigeminal Neuralgia: Prognostic Significance and Mechanistic Implications
Speaker: Shankar, Vangipuram, MD, MBBS - Apollo Proton Cancer Centre, Chennai , Tamil Nadu
11:25 AM - 11:35 AM ET

194 - Perceptual Voice Outcomes of Long-Term Head and Neck Cancer Survivors: A Multi-Listener Large Cohort Study
Speaker: McDonald, Andrew, MD, MS - University of Alabama Birmingham, Birmingham, AL
11:25 AM - 11:35 AM ET

201 - Baseline PSMA PET-Derived SUVmean as a Prognostic Factor for Lesion-Level Metabolic Response to [177Lu]Lu-PSMA-617 In Metastatic Castration-Resistant Prostate Cancer
Speaker: Strusberg, Nikolai, MD - Miami Cancer Institute: Baptist Health South Florida, Miami, FL
11:25 AM - 11:35 AM ET

207 - Patterns of Progression after BCMA CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Lesion-Level PET/CT Analysis
Speaker: Dreyfuss, Alexandra, MD, MS - University of Miami - Sylvester Cancer Center, Coral Gables, FL
11:35 AM - 11:45 AM ET

170 - KRAS Variant-Specific Chemoradiation Response and Tumor Microenvironment Characterization in Locally Advanced Rectal Cancer: An Integrated Transcriptomic Profiling
Speaker: Lasington, Jeril, MD - NYMC-Saint Clare's Health and Saint Mary's general hospital, Denville, NJ
11:35 AM - 11:45 AM ET

182 - Association Between Circulating Immunobiomarkers and Survival In Stage III Non-Small Cell Lung Cancer (NSCLC) Treated with Chemoradiation (CRT): Longitudinal Analyses from NRG-RTOG 0617
Speaker: Miccio, Joseph, MD - Penn State Hershey Medical Center, Hershey, PA